Hartalega Holdings Berhad, an investment holding company, engages in the manufacture, retail, and wholesale of latex and nitrile gloves in Malaysia, North America, Europe, rest of Asia, Australia, South America, the Middle East, Russia, and Africa. More Details
Flawless balance sheet with outstanding track record and pays a dividend.
Share Price & News
How has Hartalega Holdings Berhad's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: HARTA is not significantly more volatile than the rest of MY stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: HARTA's weekly volatility (5%) has been stable over the past year.
7 Day Return
MY Medical Equipment
1 Year Return
MY Medical Equipment
Return vs Industry: HARTA underperformed the MY Medical Equipment industry which returned -60.3% over the past year.
Return vs Market: HARTA underperformed the MY Market which returned -1.5% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Hartalega Holdings Berhad's share price compared to the market and industry in the last 5 years?
Simply Wall St News
17 hours ago | Simply Wall StHartalega Holdings Berhad (KLSE:HARTA) Will Pay A Larger Dividend Than Last Year At RM0.20
1 week ago | Simply Wall StHere's What Hartalega Holdings Berhad's (KLSE:HARTA) Shareholder Ownership Structure Looks Like
1 month ago | Simply Wall StDid You Participate In Any Of Hartalega Holdings Berhad's (KLSE:HARTA) Fantastic 275% Return ?
Is Hartalega Holdings Berhad undervalued compared to its fair value and its price relative to the market?
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: HARTA (MYR7.04) is trading below our estimate of fair value (MYR31.75)
Significantly Below Fair Value: HARTA is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: HARTA is poor value based on its PE Ratio (8.3x) compared to the MY Medical Equipment industry average (3.8x).
PE vs Market: HARTA is good value based on its PE Ratio (8.3x) compared to the MY market (17.3x).
Price to Earnings Growth Ratio
PEG Ratio: HARTA's earnings are forecast to decline next year, so we can't calculate its PEG ratio.
Price to Book Ratio
PB vs Industry: HARTA is overvalued based on its PB Ratio (4.8x) compared to the MY Medical Equipment industry average (2.6x).
How is Hartalega Holdings Berhad forecast to perform in the next 1 to 3 years based on estimates from 19 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: HARTA's earnings are forecast to decline over the next 3 years (-24.8% per year).
Earnings vs Market: HARTA's earnings are forecast to decline over the next 3 years (-24.8% per year).
High Growth Earnings: HARTA's earnings are forecast to decline over the next 3 years.
Revenue vs Market: HARTA's revenue is expected to decline over the next 3 years (-6.7% per year).
High Growth Revenue: HARTA's revenue is forecast to decline over the next 3 years (-6.7% per year).
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: HARTA's Return on Equity is forecast to be low in 3 years time (17.1%).
How has Hartalega Holdings Berhad performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: HARTA has high quality earnings.
Growing Profit Margin: HARTA's current net profit margins (43.1%) are higher than last year (14.8%).
Past Earnings Growth Analysis
Earnings Trend: HARTA's earnings have grown significantly by 43.4% per year over the past 5 years.
Accelerating Growth: HARTA's earnings growth over the past year (565.4%) exceeds its 5-year average (43.4% per year).
Earnings vs Industry: HARTA earnings growth over the past year (565.4%) exceeded the Medical Equipment industry 41.4%.
Return on Equity
High ROE: HARTA's Return on Equity (58.1%) is considered outstanding.
How is Hartalega Holdings Berhad's financial position?
Financial Position Analysis
Short Term Liabilities: HARTA's short term assets (MYR4.4B) exceed its short term liabilities (MYR1.4B).
Long Term Liabilities: HARTA's short term assets (MYR4.4B) exceed its long term liabilities (MYR439.6M).
Debt to Equity History and Analysis
Debt Level: HARTA's debt to equity ratio (6.9%) is considered satisfactory.
Reducing Debt: HARTA's debt to equity ratio has reduced from 16.5% to 6.9% over the past 5 years.
Debt Coverage: HARTA's debt is well covered by operating cash flow (900.1%).
Interest Coverage: HARTA's interest payments on its debt are well covered by EBIT (584.8x coverage).
What is Hartalega Holdings Berhad current dividend yield, its reliability and sustainability?
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: HARTA's dividend (7.24%) is higher than the bottom 25% of dividend payers in the MY market (1.51%).
High Dividend: HARTA's dividend (7.24%) is in the top 25% of dividend payers in the MY market (4.17%)
Stability and Growth of Payments
Stable Dividend: HARTA's dividends per share have been stable in the past 10 years.
Growing Dividend: HARTA's dividend payments have increased over the past 10 years.
Current Payout to Shareholders
Dividend Coverage: With its reasonably low payout ratio (46.1%), HARTA's dividend payments are well covered by earnings.
Future Payout to Shareholders
Future Dividend Coverage: HARTA's dividends in 3 years are forecast to be covered by earnings (66.1% payout ratio).
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mun Kuan (45 yo)
Mr. Mun Leong Kuan has been a Chief Executive Officer of Hartalega Holdings Berhad since May 18, 2020 and has been its Managing Director since November 16, 2012. Mr. Kuan served as Deputy Managing Director...
Experienced Management: HARTA's management team is considered experienced (2.6 years average tenure).
Experienced Board: HARTA's board of directors are considered experienced (8 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Hartalega Holdings Berhad's company bio, employee growth, exchange listings and data sources
- Name: Hartalega Holdings Berhad
- Ticker: HARTA
- Exchange: KLSE
- Founded: 1988
- Industry: Health Care Supplies
- Sector: Healthcare
- Market Cap: RM24.059b
- Shares outstanding: 3.42b
- Website: https://www.hartalega.com.my
Number of Employees
- Hartalega Holdings Berhad
- C-G-9, Jalan Dataran SD1
- Dataran SD, PJU 9
- Kuala Lumpur
- Wilayah Persekutuan
Hartalega Holdings Berhad, an investment holding company, engages in the manufacture, retail, and wholesale of latex and nitrile gloves in Malaysia, North America, Europe, rest of Asia, Australia, South Am...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/08/01 11:03|
|End of Day Share Price||2021/07/30 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.